Beauty & Aesthetic Intelligence

Source-linked product and market intelligence.

Latticepoint LLC publishes inspectable intelligence products and delivers fixed-scope reviews for skincare brands, aesthetic-device businesses, and selected Medspa operators.

Explore intelligence Review services

Research and business intelligence only. Review full interpretation limits inMethodology.

Translucent formulation and skin-like material textures on warm paper.

INTELLIGENCE LINES

Three evidence lines.

PUBLIC PROOF · PUBLISHED METHODS

Skin Signal Brief

A dated view of selected terms and patterns in approved public records, with source boundaries kept beside every chart.

Source: openFDA
Status: Published research
Output: Brief + data

Open brief

AI Product Readiness Audit

A field-level review of product identity, offers, structured data, and evidence links without turning metadata into a product-quality score.

Source: Google specs
Status: Public framework
Output: Rubric + checklist

View rubric

Aesthetic Device Evidence Watch

A record trail for one reviewed FDA product-code category, preserving classification, 510(k), recall, event, and identifier boundaries.

Source: FDA + NLM
Status: Published research
Output: Record table

Inspect records

01Skincare brands02Device brands & distributors03Medspa operators

FIXED-SCOPE SERVICES

Start with one bounded input and one named delivery.

Public products show the method. Paid work begins only after the input passes its intake check.

SERVICE 01

Beauty Catalog Change Brief

Two authorized Shopify product exports, up to 100 variant rows each

Audience: Skincare brands
Delivery: One fixed-scope delivery

No store changes, sales prediction, ad approval, or compliance grade.

SERVICE 02

Aesthetic Device Quote & Record Check

One device family, up to two authorized documents or 30 combined pages

Audience: Device brands, distributors, and selected Medspa operators
Delivery: Scoped after a document-fit check

No safety ranking, purchase advice, contract review, or compliance guarantee.

SERVICE 03

Monitoring Pilot

One scheduled refresh of the approved baseline method

Audience: Completed Audit or Brief clients
Delivery: One refresh after a completed baseline

A Monitoring Pilot is not continuous monitoring or a subscription.

Laboratory glass, formulation material, and an organized document edge.

FEATURED EVIDENCE PRACTICE

The release waits until the source chain closes.

Public records are retained before transformation, hashed, checked against a publication contract, and paired with a documented interpretation boundary. The current FDA cases passed the review and hash gates; their counts remain labeled as public report and document counts rather than population or risk estimates.

Read the source and methodology

RetainedPublic source snapshotRaw data kept before transforms

ActiveManifest checksPaths, timestamps, and hashes

ApprovedDevice allowlist reviewExact FDA product code OHS

3Approved manifestsCurrent published set